Erschienen in:
02.05.2020 | IM - COMMENTARY
Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker?
verfasst von:
Marco Falcone, Giusy Tiseo, Francesco Menichetti
Erschienen in:
Internal and Emergency Medicine
|
Ausgabe 1/2021
Einloggen, um Zugang zu erhalten
Excerpt
Biomarkers are an essential tool for the identification and monitoring of patients developing an infection, to determine their clinical severity and to assess the response to antibiotic therapy [
1]. However, the interpretation of procalcitonin (PCT) values may be challenging in subjects undergoing hemodialysis (HD), and several considerations about the use of PCT in HD patients should be done. …